PURPOSE: New-onset atrial fibrillation (NOAF) is common and associated with increased morbidity and mortality. However, its clinical importance and management in critically ill patients are not well described. The aim of this scoping review is to assess the epidemiology and management strategies of NOAF during critical illness. METHOD: The review was conducted in accordance with the PRISMA extension for scoping reviews. We searched PubMed, EMBASE and the Cochrane Library for studies assessing the incidence, outcome and management strategies of NOAF in adult critically ill patients. The quality of evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. RESULTS: A total of 99 studies were included, of which 79 were observational and 20 were interventional. The incidence of NOAF varied from 1.7% to 43.9% with considerable inter-population variation (very low quality of evidence). Commonly identified risk factors for NOAF included higher age, cardiovascular comorbidities and sepsis. The occurrence of NOAF was associated with adverse outcomes, including stroke, prolonged length of stay and mortality (very low quality of evidence). We found limited data on the optimal management strategy with no evidence for firm benefit or harm for any intervention (very low/low quality of evidence). CONCLUSIONS: The definition and incidence of NOAF in critically ill patients varied considerably and many risk factors were identified. NOAF seemed to be associated with adverse outcomes, but data were very limited and current management strategies are not evidence-based.
PURPOSE: New-onset atrial fibrillation (NOAF) is common and associated with increased morbidity and mortality. However, its clinical importance and management in critically illpatients are not well described. The aim of this scoping review is to assess the epidemiology and management strategies of NOAF during critical illness. METHOD: The review was conducted in accordance with the PRISMA extension for scoping reviews. We searched PubMed, EMBASE and the Cochrane Library for studies assessing the incidence, outcome and management strategies of NOAF in adult critically illpatients. The quality of evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. RESULTS: A total of 99 studies were included, of which 79 were observational and 20 were interventional. The incidence of NOAF varied from 1.7% to 43.9% with considerable inter-population variation (very low quality of evidence). Commonly identified risk factors for NOAF included higher age, cardiovascular comorbidities and sepsis. The occurrence of NOAF was associated with adverse outcomes, including stroke, prolonged length of stay and mortality (very low quality of evidence). We found limited data on the optimal management strategy with no evidence for firm benefit or harm for any intervention (very low/low quality of evidence). CONCLUSIONS: The definition and incidence of NOAF in critically illpatients varied considerably and many risk factors were identified. NOAF seemed to be associated with adverse outcomes, but data were very limited and current management strategies are not evidence-based.
Authors: O'Dene Lewis; Julius Ngwa; Richard F Gillum; Alicia Thomas; Wayne Davis; Vishal Poddar; George R Adams; Alvin Jr Thomas; Alem Mehari Journal: Ethn Dis Date: 2016-04-21 Impact factor: 1.847
Authors: Ari Moskowitz; Kenneth P Chen; Avraham Z Cooper; Abdullah Chahin; Mohammad M Ghassemi; Leo Anthony Celi Journal: Shock Date: 2017-10 Impact factor: 3.454
Authors: Ibrahim Migdady; Aaron Shoskes; Leen Z Hasan; Catherine Hassett; Pravin George; Christopher Newey; Sung-Min Cho; Alexander Rae-Grant; Ken Uchino Journal: Neurohospitalist Date: 2021-01-08
Authors: Laura Drikite; Jonathan P Bedford; Liam O'Bryan; Tatjana Petrinic; Kim Rajappan; James Doidge; David A Harrison; Kathryn M Rowan; Paul R Mouncey; Duncan Young; Peter J Watkinson; Mark Corbett Journal: Crit Care Date: 2021-07-21 Impact factor: 9.097
Authors: Liam Joseph O'Bryan; Oliver C Redfern; Jonathan Bedford; Tatjana Petrinic; J Duncan Young; Peter J Watkinson Journal: BMJ Open Date: 2020-03-24 Impact factor: 2.692
Authors: Maria Vittoria De Angelis; Vincenzo Di Stefano; Raffaella Franciotti; Nanda Furia; Enrico Di Girolamo; Marco Onofrj; Massimiliano Faustino Journal: Sci Rep Date: 2020-02-24 Impact factor: 4.379
Authors: S Huang; F Sanfilippo; A Herpain; M Balik; M Chew; F Clau-Terré; C Corredor; D De Backer; N Fletcher; G Geri; A Mekontso-Dessap; A McLean; A Morelli; S Orde; T Petrinic; M Slama; I C C van der Horst; P Vignon; P Mayo; A Vieillard-Baron Journal: Ann Intensive Care Date: 2020-04-25 Impact factor: 6.925